google-site-verification: googlec7193c3de77668c9.html

Recommendations developed for assessing postoperative Crohn disease recurrence

[

Recommendations developed for assessing postoperative Crohn disease recurrence

Multidisciplinary recommendations are presented to standardize intestinal ultrasound application for assessing postoperative recurrence of Crohn disease in an article published online May 20 in The Lancet Gastroenterology & Hepatology.

Christopher Ma, M.D., from The Cumming School of Medicine in Calgary, Alberta, Canada, and colleagues developed expert-based recommendations for standardizing intestinal ultrasound use for the detection and evaluation of postoperative Crohn disease recurrence after surgical bowel ileocolic resection. A list of statements related to the use of intestinal ultrasound in this setting was generated; the appropriateness of each statement was rated in two rounds of voting and classified as appropriate, inappropriate, or uncertain and then ratified.

The researchers found that during the ratification meeting, 79 statements were voted on; 67 were ratified. The colonic segment immediately distal to the anastomosis, the neoterminal ileum, neoterminal ileal inlet, colonic and ileal blind side of the anastomosis, sonographically visible colonic segments, and the surrounding mesentery were recommended anatomical components for sonographic evaluation.

For the parameters of the assessment, the authors recommended bowel wall thickness, bowel wall stratification, bowel wall vascularity, mesenteric inflammatory fat and lymphadenopathy, luminal narrowing, and the presence of complications (abscess, inflammatory mass, fistula or sinus tract, stricture and stricture length, and prestenotic dilation). To avoid confounding the interpretation of sonographic findings with immediate postoperative complications or changes associated with surgical healing, waiting at least four weeks after surgery to perform intestinal ultrasound was recommended.

“The guidance developed through this consensus aims to enhance consistency, diagnostic accuracy, and confidence in applying intestinal ultrasound to clinical practice and research settings,” the authors write.

Several authors disclosed ties to biopharmaceutical companies, including Johnson & Johnson Innovative Medicine, which funded the research.

Publication details

Christopher Ma et al, Intestinal ultrasound to detect postoperative recurrence in patients with Crohn’s disease: an international, multidisciplinary, RAND/UCLA appropriateness method study, The Lancet Gastroenterology & Hepatology (2026). DOI: 10.1016/s2468-1253(26)00082-8

Journal information:
The Lancet Gastroenterology & Hepatology


Key medical concepts

Crohn’s Disease

Clinical categories

Gastroenterology

Who’s behind this story?


Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news.

Full profile →


Andrew Zinin

Andrew Zinin

Master’s in physics with research experience. Long-time science news enthusiast. Plays key role in Science X’s editorial success.

Full profile →

Advertisements

© 2026 HealthDay. All rights reserved.

Citation:
Recommendations developed for assessing postoperative Crohn disease recurrence (2026, May 28)
retrieved 29 May 2026
from https://medicalxpress.com/news/2026-05-postoperative-crohn-disease-recurrence.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.




Source link

Views: 1

See also  Cancer risk awareness and concrete plans boosted gastric screening during COVID-19

Check Also

Growing scientific evidence links e-cigarette chemicals to heart health risks

[ Is vaping bad for my health? As people who use e-cigarettes and their loved …

Amos: There needs to be a 'set of standards' for care

Review chair Baroness Valerie Amos recommends changes to overhaul the NHS maternity care system. BBC …

New T‑cell therapy targets three tumor proteins, shows early survival gains in aggressive pediatric brain cancers

[ Researchers report encouraging early results from a first-in-human clinical trial led by Children’s National …

Leave a Reply

Available for Amazon Prime
electric scooter guides.